Mohammad Haji Aghajani1, Mohammad Parsa Mahjoob2, Abdolreza Babamahmoodi3

  • 1Prevention of Cardiovascular Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

PubMed
概括

左主冠状动脉疾病 (LMCAD) 影响4.38%的患者. 对于量身定制的患者管理,LMCAD呈现和并发症的性别特异性差异是显著的.